Four-decade trends in lymph node status of patients with vulvar squamous cell carcinoma in northern Italy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 03 2021
Historique:
received: 21 05 2020
accepted: 16 02 2021
entrez: 12 3 2021
pubmed: 13 3 2021
medline: 15 12 2021
Statut: epublish

Résumé

The 4-decade (1980-2017) trends in lymph node status of patients with vulvar squamous cell carcinoma (VSCC) in a province of northern Italy were investigated. Information was collected on lymph node dissection, number of lymph nodes dissected, lymph node involvement, and number of positive lymph nodes from a series of 760 patients admitted to a tertiary referral centre for vulvar disease. The adjusted odds ratios (ORs) for lymph node involvement, for ≥ 2 positive nodes, and for a lymph node ratio ≥ 20% were estimated from multiple logistic regression models. The adjusted OR for lymph node dissection was greater in the 2000s and 2010s versus the 1980s. The adjusted OR for lymph node involvement was 1.36 (95% confidence interval (CI), 0.72-2.60) in the 1990s, 1.31 (95% CI, 0.72-2.38) in the 2000s and 1.32 (95% CI, 0.73-2.41) in the 2010s versus the 1980s. The adjusted OR for ≥ 2 positive nodes was 1.36 (95% CI, 0.68-2.72), 0.86 (95% CI, 0.44-1.65) and 0.67 (95% CI, 0.34-1.31), respectively. The adjusted OR for lymph node ratio ≥ 20% was 1.45 (95% CI, 0.62-3.43), 1.21 (95% CI, 0.54-2.72) and 0.81 (95% CI, 0.35-1.89), respectively. This stagnation indicates the need for a serious rethink of the local model for the care of VSCC.

Identifiants

pubmed: 33707570
doi: 10.1038/s41598-021-85030-x
pii: 10.1038/s41598-021-85030-x
pmc: PMC7952703
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5661

Références

Crit Rev Oncol Hematol. 2012 Jul;83(1):71-83
pubmed: 22015047
BJOG. 2014 May;121(6):728-38; discussion 739
pubmed: 24148762
J Reprod Med. 1993 Jan;38(1):28-32
pubmed: 8441127
Croat Med J. 2005 Jun;46(3):436-42
pubmed: 15861524
Eur J Cancer. 2013 Dec;49(18):3872-80
pubmed: 24011936
Int J Gynecol Cancer. 2009 May;19(4):752-5
pubmed: 19509583
J Surg Oncol. 2002 Sep;81(1):19-24
pubmed: 12210022
Am J Obstet Gynecol. 1991 Apr;164(4):997-1003; discussion 1003-4
pubmed: 2014852
J Low Genit Tract Dis. 2018 Jul;22(3):242-250
pubmed: 29570138
Gynecol Oncol. 2011 Jul;122(1):45-9
pubmed: 21474166
Acta Oncol. 2010 Jun;49(5):632-43
pubmed: 20307243
Gynecol Oncol. 2017 Dec;147(3):521-527
pubmed: 29037807
J Thorac Cardiovasc Surg. 1997 Jan;113(1):37-49
pubmed: 9011700
Prim Care. 1992 Sep;19(3):607-20
pubmed: 1410066
Int J Gynecol Cancer. 2012 Jun;22(5):854-9
pubmed: 22426405
Acta Oncol. 2018 Mar;57(3):324-330
pubmed: 28799431
J Reprod Med. 1990 Dec;35(12):1134-7
pubmed: 2283631
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S7-27
pubmed: 17161169
Int J Gynaecol Obstet. 2014 May;125(2):97-8
pubmed: 24630859
J Obstet Gynaecol. 2014 Feb;34(2):165-8
pubmed: 24456439
Eur J Surg Oncol. 2015 Apr;41(4):592-8
pubmed: 25638604
Gynecol Oncol. 2018 Mar;148(3):622-631
pubmed: 29137809
Gynecol Oncol. 2008 Jun;109(3):340-5
pubmed: 18407339
Br J Cancer. 2019 Jun;120(12):1153-1161
pubmed: 31105271
Gynecol Oncol. 2004 Dec;95(3):701-5
pubmed: 15581985
Gynecol Oncol. 2014 Aug;134(2):314-8
pubmed: 24875124
Gynecol Oncol. 2017 Jun;145(3):543-548
pubmed: 28356187
Ann Surg Oncol. 2007 Jul;14(7):2128-32
pubmed: 17473950
BMC Health Serv Res. 2017 Jul 11;17(Suppl 1):457
pubmed: 28722550
Acta Orthop. 2017 Jun;88(3):341-347
pubmed: 28266233
Gynecol Oncol. 2010 May;117(2):308-11
pubmed: 20153883
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120
pubmed: 26951748
Gynecol Oncol. 1993 Jun;49(3):279-83
pubmed: 8314530
Obstet Gynecol. 2009 Sep;114(3):537-546
pubmed: 19701032
Int J Gynecol Pathol. 2006 Apr;25(2):176-81
pubmed: 16633069
Gynecol Oncol. 2019 May;153(2):286-291
pubmed: 30760408
Cancer. 2000 Apr 15;88(8):1869-76
pubmed: 10760764
Obstet Gynecol. 1983 Apr;61(4):408-12
pubmed: 6828268
Obstet Gynecol. 1983 Jan;61(1):63-74
pubmed: 6823350
Cancer. 1997 Aug 1;80(3):505-13
pubmed: 9241085
J R Soc Med. 1996 Dec;89(12):699-701
pubmed: 9014882
Anticancer Res. 2009 Feb;29(2):545-52
pubmed: 19331201
J Low Genit Tract Dis. 2012 Oct;16(4):398-402
pubmed: 22652575
Tumori. 2019 Apr;105(2):121-137
pubmed: 30917768
Gynecol Oncol. 2006 Aug;102(2):333-7
pubmed: 16466657
Int J Gynecol Cancer. 2015 Nov;25(9):1683-9
pubmed: 26495761
Gynecol Oncol. 2003 Nov;91(2):378-82
pubmed: 14599869
Int J Gynecol Cancer. 2009 Oct;19(7):1276-80
pubmed: 19823065

Auteurs

Mario Preti (M)

Department of Surgical Sciences, University of Torino, Torino, Italy.

Lauro Bucchi (L)

Romagna Cancer Registry, Romagna Cancer Institute (IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) "Dino Amadori"), Meldola, Forlì, Italy. lauro.bucchi@irst.emr.it.

Leonardo Micheletti (L)

Department of Surgical Sciences, University of Torino, Torino, Italy.

Silvana Privitera (S)

Department of Pathology, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza, Torino, Italy.

Monica Corazza (M)

Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.

Stefano Cosma (S)

Department of Surgical Sciences, University of Torino, Torino, Italy.

Niccolò Gallio (N)

Department of Surgical Sciences, University of Torino, Torino, Italy.

Alessandro Borghi (A)

Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.

Federica Bevilacqua (F)

Department of Surgical Sciences, University of Torino, Torino, Italy.

Chiara Benedetto (C)

Department of Surgical Sciences, University of Torino, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH